person · Reporting owner
Gosbee George Frederick John
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcadia Biosciences, Inc.RKDA · Entity 8593 | Director | June 07, 2017 | June 16, 2017 |
| BioAmber Inc.BIOA · Entity 167805 | Director | November 09, 2016 | November 14, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcadia Biosciences, Inc.
Report date June 07, 2017 · Filed June 16, 2017 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.73 · Expires 2027-06-07 | Direct | 140,816 |
Reported balance
Holding disclosure · report date 2017-06-07 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 140,816 F1: 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service. F2: This filing is to correct the number of options granted on June 7, 2017 to 140,816. All other information remain the same. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.
F2: This filing is to correct the number of options granted on June 7, 2017 to 140,816. All other information remain the same.
BioAmber Inc.
Report date November 09, 2016 · Filed November 14, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,000 |
Reported balance
After 2016-11-09 transaction · row 1
1 source rowRow 1 · 2016-11-09 · Purchase · Acquired 25,000 · Balance 25,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2017 Filed Jun 9, 2017 21:45 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 80,466 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-17-038953 · doc4.xml · derivative · entry 1 Gosbee George Frederick John · CIK 0001518989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,466 Underlying: Common Stock · 80,466 shares Expires 2027-06-07 F1 · derivative.exercise_date: The Option will become 100% vested and excercisable on the earlier to occur of (i) June 7, 2018 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Particpant's continued service. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 08:55 UTC | BioAmber Inc. BIOA · Entity 167805 | PurchaseCommon Stock | 25,000 | $3.87 | $96,630.00 |
DisclosureSEC source: 0001209191-16-149543 · doc4.xml · nonDerivative · entry 1 Gosbee George Frederick John · CIK 0001518989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.